Latest News

10.23.20

Moderna Hits 30,000 Enrollment Target in Phase 3 Coronavirus Vaccine Trial

Source: FirstWord

10.23.20

Gilead’s Veklury Becomes First Treatment to Receive FDA Approval for COVID-19

Source: FirstWord

10.22.20

Suspected Control Group Participant in AstraZeneca COVID-19 Vaccine Study Dies; Trial Continues

Source: FirstWord

10.22.20

Myopia Profile and Essilor Partner to Tackle Childhood Myopia Through Education and Awareness

Source: Essilor

10.22.20

CDC Warns of “Distressing Trend” With Increased COVID-19 Cases Across Nearly 75% of the Country

Source: FierceHealthcare

10.21.20

Tarsus Pharmaceuticals Announces Closing of Initial Public Offering

Source: Tarsus Pharmaceuticals

10.21.20

The Vision Council Announces Dates for the 2021 Virtual Executive Summit: January 26–28, 2021

Source: The Vision Council

10.21.20

Outpatient Visits Rebound for Most Specialties to Pre-COVID Levels

Source: Medscape

10.21.20

Sources Say US Study of AstraZeneca’s COVID-19 Vaccine May Restart This Week

Source: FirstWord

10.20.20

Volunteers to be Infected With Coronavirus in World’s First ‘Human Challenge’ Trials

Source: Financial Times

View more stories